The subject of this order is the successive delivery to the Prison No. 2 in Łódź of medicinal products and medical devices used in respiratory, eye and ear diseases, defined in the Common Procurement Vocabulary (CPV) with code number 33600000 - 6 as "pharmaceutical products", and products medical and foodstuffs for particular nutritional uses 'CPV 33690000-3 from the group' Various medicinal products in estimated quantities and in the assortment indicated in the tabular sets constituting Annex 1 to the specification of essential terms of the contract. The Purchaser declares that whenever the Purchaser used the trade names of medicines, medical devices and foods for particular nutritional uses in the assortment form, he did so in accordance with art. 29 paragraph 3 of the Public Procurement Law Act solely for the purpose of precisely specifying the active substance or active substance composition (or intended use) contained in the ordered medicines and foodstuffs for particular nutritional uses, or specifying medical devices. The use of these names means only that the Employer requests the offer of products containing these active substances or compositions of active substances as the products whose names have been used and allows offering both the same products and equivalent products, which should be understood as identical in terms of composition of active substances, intended use and effect as well as method of administration. In the case of medicinal products administered orally, a change may be made, for example, to dragee tablets, dragees for capsules, tablets for coated tablets, ampoules for vials, etc., except as described in 3.2.6. The Purchaser does not allow the exchange of soluble tablets for ordinary ones. It also does not allow substitution in terms of duration of action, preparations with prolonged action cannot be replaced with those with unmodified release time of the active substance. The Purchaser acknowledges that the prolonged-action tablets correspond to modified-release tablets. The same principles apply accordingly to medical devices

The subject of this contract is the successive delivery to the Prison No. 2 in Łódź of medicinal products and medical devices used in respiratory, eye and ear diseases, defined in the Common Procurement Vocabulary (CPV) with code number 33600000 - 6 as "pharmaceutical products", and products medical and foodstuffs for particular nutritional uses 'CPV 33690000-3 from the group' Various medicinal products in estimated quantities and in the assortment indicated in the tabular sets constituting Annex 1 to the specification of essential terms of the contract. The Purchaser declares that whenever the Purchaser used the trade names of medicines, medical devices and foods for particular nutritional uses in the assortment form, he did so in accordance with art. 29 paragraph 3 of the Public Procurement Law Act solely for the purpose of precisely specifying the active substance or active substance composition (or intended use) contained in the ordered medicines and foodstuffs for particular nutritional uses, or specifying medical devices. The use of these names means only that the Employer requests the offer of products containing these active substances or compositions of active substances as the products whose names have been used and allows offering both the same products and equivalent products, which should be understood as identical in terms of composition of active substances, intended use and effect as well as method of administration. In the case of medicinal products administered orally, a change may be made, for example, to dragee tablets, dragees for capsules, tablets for coated tablets, ampoules for vials, etc., except as described in 3.2.6. The Purchaser does not allow the exchange of soluble tablets for ordinary ones. It also does not allow substitution in terms of duration of action, preparations with prolonged action cannot be replaced with those with unmodified release time of the active substance. The Purchaser acknowledges that the prolonged-action tablets correspond to modified-release tablets. The same principles apply accordingly to medical devices